Liminal BioSciences
(NASDAQ) LMNL
Liminal BioSciences Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$492.00K
Net Income (TTM)
$354.00K
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
LMNL News
LMNL: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Liminal BioSciences
Industry
Biotechnology
Sector
Health CareEmployees
43
CEO
Bruce Philip Pritchard
Website
www.liminalbiosciences.comHeadquarters
Laval, QC H7V 4B4, CA
LMNL Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-82%
Net Income Margin
-72%
Return on Equity
-73%
Return on Capital
-82%
Return on Assets
-57%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$401.00K
Operating Income
$32.98M
EBITDA
$31.86M
Operating Cash Flow
$31.82M
Capital Expenditure
$19.00K
Free Cash Flow
$31.84M
Cash & ST Invst.
$37.14M
Total Debt
$1.49M
Liminal BioSciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$112.00K
-28.7%
Gross Profit
$112.00K
-28.7%
Gross Margin
100.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
251
N/A
Net Income
$9.14M
-192.2%
EBITDA
$8.86M
-65.6%
Quarterly Fundamentals
Net Cash
$18.11M
-44.6%
Accounts Receivable
$788.00K
-46.8%
Inventory
$0.00
N/A
Long Term Debt
$528.00K
-96.1%
Short Term Debt
$679.00K
-92.9%
Return on Assets
-57.31%
N/A
Return on Invested Capital
-81.71%
N/A
Free Cash Flow
$7.78M
-14.6%
Operating Cash Flow
$7.78M
-14.8%